Benzodiazepines Flashcards
Midazolam (Versed)
Drug Class
&
MOA
Benzodiazepine
Binds to BZD site between subunits α1 & γ2 of GABAA receptor
Increases affinity of GABA to receptor & enhancing opening of Cl- channels resulting in IPSP
Midazolam (Versed)
Sedation Dose
Adult
IV: 1-5 mg
Midazolam (Versed)
Sedation Dose
Pediatric
PO: 0.25-0.5 mg/kg
Midazolam (Versed)
Induction Dose
IV: 0.1-0.2 mg
Over 30-60 sec
Midazolam (Versed)
Onset
Peak
Duration
Half-life
Onset
IV: 1-2 min
Peak
IV: 5 min
Duration
IV: 5-10 min
Half-life
2 hrs
Midazolam (Versed)
Metabolism & Elimination
Metabolism
Hepatic: CYP3A4
Elimination
Kidneys
Active Metabolite
1-hydroxymidazolam
Midazolam (Versed)
Side Effects
CNS
↓ CMRO2, ↓ CBF
Respiratory
↓ in ventilation
↓ hypoxic drive
Cardiovascular
↓ BP ↑ HR
Diazepam (Valium)
Drug Class
&
MOA
Benzodiazepine
Binds to BZD site between subunits α1 & γ2 of GABAA receptor
Increases affinity of GABA to receptor & enhancing opening of Cl- channels resulting in IPSP
Diazepam (Valium)
Induction Dose
IV: 0.5-1 mg/kg
Diazepam (Valium)
Anti-convulsant Dose
IV: 0.1 mg/kg
Diazepam (Valium)
Onset
Peak
Duration
Half-life
Onset
IV: 1-5 min
Peak
IV: 15 min
Duration
IV: 15-30 min
Half-life
20-40 hrs
Diazepam (Valium)
Metabolism & Elimination
Metabolism
Hepatic: CYP3A4
Elimination
Kidneys
Active Metabolite
Desmethyldiazepam & oxazepam
Diazepam (Valium)
Side Effects
CNS
Potent anti-convulsant
Can produce isoelectric EEG
Return to drowsiness within 6-8 hrs d/t active metabolite
Respiratory
Slight ↓ in ventilation
Cardiovascular
Min ↓ in BP, CO, & SVR
Pain on injection site d/t propylene glycol
Lorazepam (Ativan)
Drug Class
&
MOA
Benzodiazepine
Binds to BZD site between subunits α1 & γ2 of GABAA receptor
Increases affinity of GABA to receptor & enhancing opening of Cl- channels resulting in IPSP
Lorazepam (Ativan)
Sedation Dose
IV: 1-4 mg
Lorazepam (Ativan)
Onset
Peak
Duration
Half-life
Onset
IV: 1-2 min
Peak
IV: 20-30 min
Duration
IV: 6-10 hrs
Half-life
14 hrs
Lorazepam (Ativan)
Metabolism & Elimination
Metabolism
Hepatic: Conjugated to inactive metabolites
Flumazenil (Romazicon)
Drug Class
&
MOA
Benzodiazepine reversal agent
Competitive antagonist to BZD site
of GABAA receptor
Prevents/reverses all agonist activity of BZD
Flumazenil (Romazicon)
Dosing
IV: 0.2 mg; followed by 0.1 mg q 1 min Titrated to Effect
Sedation Reversal: 0.3-0.6 mg
COMPLETE Reversal: 0.5-1 mg
Flumazenil (Romizicon)
Onset
Duration
Onset
IV: 1-2 min
Duration
IV: 30-60 min
Flumazenil (Romazicon)
Metabolism & Elimination
Metabolism
Hepatic: CYP450 to inactive metabolites
Flumazenil (Romazicon)
Contraindication
Contraindicated with anti-epileptic drugs